Literature DB >> 24311845

Nigella sativa concoction induced sustained seroreversion in HIV patient.

Abdulfatah Adekunle Onifade1, Andrew Paul Jewell, Waheed Adeola Adedeji.   

Abstract

Nigella sativa had been documented to possess many therapeutic functions in medicine but the least expected is sero-reversion in HIV infection which is very rare despite extensive therapy with highly active anti-retroviral therapy (HAART). This case presentation is to highlight the complete recovery and sero-reversion of adult HIV patient after treatment with Nigella sativa concoction for the period of six months. The patient presented to the herbal therapist with history of chronic fever, diarrhoea, weight loss and multiple papular pruritic lesions of 3 months duration. Examination revealed moderate weight loss, and the laboratory tests of ELISA (Genscreen) and western blot (new blot 1 & 2) confirmed sero-positivity to HIV infection with pre-treatment viral (HIV-RNA) load and CD4 count of 27,000 copies/ml and CD4 count of 250 cells/ mm(3) respectively. The patient was commenced on Nigella sativa concoction 10 mls twice daily for 6 months.. He was contacted daily to monitor side-effects and drug efficacy. Fever, diarrhoea and multiple pruritic lesions disappeared on 5th, 7th and 20th day respectively on Nigella sativa therapy. The CD4 count decreased to 160 cells/ mm3 despite significant reduction in viral load (≤1000 copies/ml) on 30th day on N. sativa. Repeated EIA and Western blot tests on 187th day on Nigella sativa therapy was sero-negative. The post therapy CD4 count was 650 cells/ mm(3) with undetectable viral (HIV-RNA) load. Several repeats of the HIV tests remained sero-negative, aviraemia and normal CD4 count since 24 months without herbal therapy. This case report reflects the fact that there are possible therapeutic agents in Nigella sativa that may effectively control HIV infection.

Entities:  

Keywords:  HIV infection; Nigella sativa; sero-reversion

Mesh:

Substances:

Year:  2013        PMID: 24311845      PMCID: PMC3847425     

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  19 in total

1.  HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil.

Authors:  Suzanne Jurriaans; Sanjay U C Sankatsing; Jan M Prins; Hanneke Schuitemaker; Joep Lange; Antoinette C Van Der Kuyl; Marion Cornelissen
Journal:  AIDS       Date:  2004-07-23       Impact factor: 4.177

2.  Spontaneous HIV-1 seroreversion in an adult male.

Authors:  Katherine M Coyne; John V Parry; Mark Atkins; Anton Pozniak; Alan McOwan
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

3.  Black seed, Nigella sativa, deserves more attention.

Authors:  Mohammad Akram Randhawa
Journal:  J Ayub Med Coll Abbottabad       Date:  2008 Apr-Jun

Review 4.  Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998 - 2007).

Authors:  Paul Cos; Louis Maes; Arnold Vlietinck; Luc Pieters
Journal:  Planta Med       Date:  2008-07-31       Impact factor: 3.352

Review 5.  Viral dynamics in HIV-1 infection.

Authors:  D Finzi; R F Siliciano
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

6.  Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.

Authors:  H R W Dharmaratne; G T Tan; G P K Marasinghe; J M Pezzuto
Journal:  Planta Med       Date:  2002-01       Impact factor: 3.352

7.  The antibacterial properties of the Nigella sativa l. seeds. Active principle with some clinical applications.

Authors:  H H Toppozada; H A Mazloum; M el-Dakhakhny
Journal:  J Egypt Med Assoc       Date:  1965

8.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

Review 9.  Recent advances in traditional plant drugs and orchids.

Authors:  Jin-Ming Kong; Ngoh-Khang Goh; Lian-Sai Chia; Tet-Fatt Chia
Journal:  Acta Pharmacol Sin       Date:  2003-01       Impact factor: 6.150

10.  Specific eradication of HIV-1 from infected cultured cells.

Authors:  Aviad Levin; Zvi Hayouka; Assaf Friedler; Abraham Loyter
Journal:  AIDS Res Ther       Date:  2010-08-19       Impact factor: 2.250

View more
  9 in total

Review 1.  Thymoquinone's Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge.

Authors:  Maen Abdelrahim; Abdullah Esmail; Noor Al Saadi; Eva Zsigmond; Ebtesam Al Najjar; Doaa Bugazia; Hadeel Al-Rawi; Ayat Alsaadi; Ahmed O Kaseb
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

2.  A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2.

Authors:  Hassan Bencheqroun; Yasir Ahmed; Mehmet Kocak; Enrique Villa; Cesar Barrera; Mariya Mohiuddin; Raul Fortunet; Emmanuel Iyoha; Deborah Bates; Chinedu Okpalor; Ola Agbosasa; Karim Mohammed; Stephen Pondell; Amr Mohamed; Yehia I Mohamed; Betul Gok Yavuz; Mohamed O Kaseb; Osama O Kasseb; Michelle York Gocio; Peter Tsu-Man Tu; Dan Li; Jianming Lu; Abdulhafez Selim; Qing Ma; Ahmed O Kaseb
Journal:  Pathogens       Date:  2022-05-07

Review 3.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

4.  Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach.

Authors:  Shabir Ahmad Mir; Ahmad Firoz; Mohammed Alaidarous; Bader Alshehri; Abdul Aziz Bin Dukhyil; Saeed Banawas; Suliman A Alsagaby; Wael Alturaiki; Gulzar Ahmad Bhat; Faizan Kashoo; Ahmad M Abdel-Hadi
Journal:  Saudi J Biol Sci       Date:  2021-09-08       Impact factor: 4.219

5.  The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial.

Authors:  Khalid A Bin Abdulrahman; Abdullah Omar Bamosa; Abdullah I Bukhari; Intisar Ahmad Siddiqui; Mostafa A Arafa; Ashfaq A Mohsin; Mamdouh Faleh Althageel; Majed Owed Aljuaeed; Ibrahim Mohammed Aldeailej; Abdulaziz Ibrahim Alrajeh; Kamel Mohamed Aldosari; Najat Ahmed Hawsawi; Khalid Ibrahim Zawbaee; Saad Mohammed Alsurayea
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

6.  Panacea seed "Nigella": A review focusing on regenerative effects for gastric ailments.

Authors:  Shahida A Khan; Aziz M Khan; Sajjad Karim; Mohammad Amjad Kamal; Ghazi A Damanhouri; Zeenat Mirza
Journal:  Saudi J Biol Sci       Date:  2014-10-13       Impact factor: 4.219

Review 7.  Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone.

Authors:  Alireza Tavakkoli; Vahid Mahdian; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  J Pharmacopuncture       Date:  2017-09-30

Review 8.  Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure.

Authors:  Mohammad Nazrul Islam; Khandkar Shaharina Hossain; Partha Protim Sarker; Jannatul Ferdous; Md Abdul Hannan; Md Masudur Rahman; Dinh-Toi Chu; Md Jamal Uddin
Journal:  Phytother Res       Date:  2020-10-12       Impact factor: 6.388

Review 9.  Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies.

Authors:  Dr Abdulrahman E Koshak; Prof Emad A Koshak
Journal:  Curr Ther Res Clin Exp       Date:  2020-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.